hcp.stratticetissuematrix.comHealthcare Professional Official Site ─ STRATTICE™ Reconstructive Tissue Matrix

Important Safety Information | Instructions For Use | Reimbursement Support | Home Products Strattice™ RTM STRATTICE™ RTM Perforated STRATTICE™ RTM Extra Thick STRATTICE™ RTM Laparoscopic About Indications and Applications Tissue Processing Mechanism of Action and Preclinical Outcomes Extensively Studied Resources Home Products Strattice™ RTM STRATTICE™ RTM Perforated STRATTICE™ RTM Extra Thick STRATTICE™ RTM Laparoscopic About Indications and Applications Tissue Processing Mechanism of Action and Preclinical Outcomes Extensively Studied Resources The industry leader for biological tissue matrices in complex abdominal wall reconstruction 1,2 STRATTICE™ Reconstructive Tissue Matrix (RTM) is a porcine-derived acellular dermal matrix that has demonstrated efficacy in the reinforcement of abdominal wall reconstruction. 1 PROPRIETARY TECHNOLOGY Our proprietary processing method supports integration. 3-5,* Learn More * As seen in animal models. Correlation of these results to results in humans is not established. SPECIALIZED PRODUCTS Multiple product variations are available to suit your surgical needs. Learn More RESOURCES View and download information about STRATTICE ™ RTM. Learn More REPLACEMENT GUARANTEE Allergan offers a replacement guarantee for all STRATTICE™ RTM products. REIMBURSEMENT SUPPORT Mon–Fri 8 am–6 pm ET Phone: 888.543.3656 Fax: 877.499.2986 LifeCell@ReimbursementAccess.com Learn More References: 1. Data on file, Allergan. 2017; 2. Total Procedure Volumes of Biologics as reported by IMS CDM for Ventral/Incisional Procedures. Sept, 2017; 3. Sun WQ, Xu H, Sandor M, Lombardi J . Process-induced extracellular matrix alterations affect the mechanisms of soft tissue repair and integration. J Tissue Eng . 2013;4:204173141350530. doi: 10.1177/2041731413505305; 4. Xu H, Wan H, Zuo W, et al. A porcine-derived acellular dermal scaffold that supports soft tissue regeneration: removal of terminal galactose-alpha-(1,3)-galactose and retention of matrix structure. Eng Part A;15(7):1807-1819; 5. Connor J, McQuillan D, Sandor M, et al. Retention of structural and biochemical integrity in a biological mesh supports tissue remodeling in a primate abdominal wall model. Regen Med. 2009;4(2):185-195. STRATTICE™ RTM, STRATTICE™ RTM Perforated, STRATTICE™ RTM Extra Thick, and STRATTICE™ RTM Laparoscopic Indicationws and Important Safety Information ▲ STRATTICE™ RTM, STRATTICE™ RTM Perforated, STRATTICE™ RTM Extra Thick, and STRATTICE™ RTM Laparoscopic Indications and Important Safety Information ▼ INDICATIONS AND IMPORTANT SAFETY INFORMATION INDICATIONS STRATTICE™ Reconstructive Tissue Matrix (RTM), STRATTICE™ RTM Perforated, STRATTICE™ RTM Extra Thick, and STRATTICE™ RTM Laparoscopic are intended for use as soft tissue patches to reinforce soft tissue where weakness exists and for the surgical repair of damaged or ruptured soft tissue membranes. Indications for use of these products include the repair of hernias and/or body wall defects which require the use of reinforcing or bridging material to obtain the desired surgical outcome. STRATTICE™ RTM Laparoscopic is indicated for such uses in open or laparoscopic procedures. These products are supplied sterile and are intended for single patient one-time use only. IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS These products should not be used in patients with a known sensitivity to porcine material and/or Polysorbate 20. WARNINGS Do not resterilize. Discard all open and unused portions of these devices. Do not use if the package is opened or damaged. Do not use if seal is broken or compromised. After use, handle and dispose of all unused product and packaging in accordance with accepted medical practice and applicable local, state, and federal laws and regulations. Do not reuse once the surgical mesh has been removed from the packaging and/or is in contact with a patient. This increases risk of patient-to-patient contamination and subsequent infection. For STRATTICE™ RTM Extra Thick, do not use if the temperature monitoring device does not display “OK.” PRECAUTIONS Discard these products if mishandling has caused possible damage or contamination, or the products are past their expiration date. Ensure these products are placed in a sterile basin and covered with room temperature sterile saline or room temperature sterile lactated Ringer’s solution for a minimum of 2 minutes prior to implantation in the body. Place these products in maximum possible contact with healthy, well-vascularized tissue to promote cell ingrowth and tissue remodeling. These products should be hydrated and moist when the package is opened. If the surgical mesh is dry, do not use. Certain considerations should be used when performing surgical procedures using a surgical mesh product. Consider the risk/benefit balance of use in patients with significant co-morbidities; including but not limited to, obesity, smoking, diabetes, immunosuppression, malnourishment, poor tissue oxygenation (such as COPD), and pre- or post-operative radiation. Bioburden-reducing techniques should be utilized in significantly contaminated or infected cases to minimize contamination levels at the surgical site, including, but not limited to, appropriate drainage, debridement, negative pressure therapy, and/or antimicrobial therapy prior and in addition to implantation of the surgical mesh. In large abdominal wall defect cases where midline fascial closure cannot be obtained, with or without separation of components techniques, utilization of the surgical mesh in a bridged fashion is associated with a higher risk of hernia recurrence than when used to reinforce fascial closure. For STRATTICE™ RTM Perforated, if a tissue punch-out piece is visible, remove using aseptic technique before implantation. For STRATTICE™ RTM Laparoscopic, refrain from using excessive force if inserting the mesh through the trocar. STRATTICE ™ RTM, STRATTICE ™ RTM Perforated, STRATTICE ™ RTM Extra Thick, and STRATTICE ™ RTM Laparoscopic are available by prescription only. For more information, please see the Instructions for Use (IFU) for all STRATTICE ™ RTM products. To report an adverse reaction, please call Allergan at 1.800.367.5737. INDICATIONS AND IMPORTANT SAFETY INFORMATION INDICATIONS STRATTICE™ Reconstructive Tissue Matrix (RTM), STRATTICE™ RTM Perforated, STRATTICE™ RTM Extra Thick, and STRATTICE™ RTM Laparoscopic are intended for use as soft tissue patches to reinforce soft tissue where weakness exists and for the surgical repair of damaged or ruptured soft tissue membranes. Indications for use of these products include the repair of hernias and/or body wall defects which require the use of reinforcing or bridging material to obtain the desired surgical outcome. STRATTICE™ RTM Laparoscopic is indicated for such uses in open or laparoscopic procedures. These products are supplied sterile and are intended for single patient one-time use only. IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS These products should not be used in patients with a known sensitivity to porcine material and/or Polysorbate 20. WARNINGS Do not resterilize. Discard all open and unused portions of these devices. Do not use if the package is opened or damaged. Do not use if seal is broken or compromised. After use, handle and dispose of all unused product and packaging in accordance with accepted medical practice and applicable local, state, and federal laws and regulations. Do not reuse once the surgical mesh has been removed from the packaging and/or is in contact with a patient. This increases risk of patient-to-patient contamination and subsequent infection. For STRATTICE™ RTM Extra Thick, do not use if the temperature monitoring device does not display “OK.” PRECAUTIONS Discard these products if mishandling has caused possible damage or contamination, or the products are past their expiration date. Ensure these products are placed in a sterile basin and covered with room temperature sterile saline or room tem...